A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
Public ClinicalTrials.gov record NCT01730027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double Blind, Placebo-Controlled, Multi-Centre, Parallel Group Study to Evaluate the Efficacy and Safety of ADC3680 Administered Once Daily as an Add-On Therapy to Inhaled Corticosteroids and When Co-Administered With Montelukast in Subjects With Inadequately-Controlled Asthma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomised, double-blind, placebo-controlled study will evaluate the efficacy and safety of ADC3680 administered once daily as an add-on therapy to inhaled corticosteroids and when co-administered with montelukast in patients with inadequately-controlled asthma. Patients will be randomised to 3 Arms to receive ADC3680, placebo or montelukast.
Study identification
- NCT ID
- NCT01730027
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 248 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2013
- Primary completion
- Nov 30, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Oct 5, 2017
2013 – 2014
United States locations
- U.S. sites
- 35
- U.S. states
- 20
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pulmagen Investigational Site | Birmingham | Alabama | — | — |
| Pulmagen Investigational Site | Huntington Beach | California | 922647 | — |
| Pulmagen Investigational Site | Riverside | California | — | — |
| Pulmagen Investigational Site | Rolling Hills | California | 90274 | — |
| Pulmagen Investigational Site | San Jose | California | — | — |
| Pulmagen Investigational Site | Colorado Springs | Colorado | — | — |
| Pulmagen Investigational Site | Waterbury | Connecticut | 6708 | — |
| Pulmagen Investigational Site | Lawrenceville | Georgia | 30046 | — |
| Pulmagen Investigational Site | Eagle | Idaho | 83616 | — |
| Pulmagen Investigational Site | Nottingham | Maryland | 21236 | — |
| Pulmagen Investigational Site | Plymouth | Minnesota | — | — |
| Pulmagen Investigational Site | Bellevue | Nebraska | 68123 | — |
| Pulmagen Investigational Site | Brick | New Jersey | — | — |
| Pulmagen Investigatinal Site | Clemmons | North Carolina | 27012 | — |
| Pulmagen Investigational Site | Canton | Ohio | — | — |
| Pulamgen Investigational Site | Cincinnati | Ohio | 45231 | — |
| Pulmagen Investigational Site | Maumee | Ohio | — | — |
| Pulmagen Investigational Site | Oklahoma City | Oklahoma | — | — |
| Pulmagen Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pulmagen Investigational Site | Medford | Oregon | — | — |
| Pulmagen Investigational Site | Portland | Oregon | — | — |
| Pulmagen Investigational Site | East Providence | Rhode Island | — | — |
| Pulmagen Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pulmagen Investigational Site | Charleston | South Carolina | — | — |
| Pulmagen Investigational Site | Fort Mill | South Carolina | 29707 | — |
| Pulmagen Investigational Site | Arlington | Texas | — | — |
| Pulmagen Investigational Site | Austin | Texas | — | — |
| Pulmagen Investigational Site | Houston | Texas | 77099 | — |
| Pulmagen Investigational Site | Killeen | Texas | — | — |
| Pulmagen Investigational Site | Waco | Texas | — | — |
| Pulmagen Investgational Site | Woodway | Texas | 76712 | — |
| Pulmagen Investigational Site | Draper | Utah | — | — |
| Pulmagen Investigational Site | Seattle | Washington | — | — |
| Pulmagen Investigational Site | Tacoma | Washington | 98405 | — |
| Pulmagen Investigational Site | Greenfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01730027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2017 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01730027 live on ClinicalTrials.gov.